BEIGENE, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172.8 USD | +1.06% |
|
+7.27% | -4.16% |
| May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
| May. 09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 18.08B | - | |||||
| 115B | ||||||
| 106B | ||||||
| 21.96B | - | |||||
| 21.87B | - | |||||
| 19.21B |
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
- Sector Chart
